|This Slide: #24 of 100|
Slide #24. BioTelemetry, Inc. — Mednet Healthcare Technologies, Inc.
BioTelemetry, Inc. (NASDAQ:BEAT)
Mednet Healthcare Technologies, Inc.
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a significant victory in the patent infringement case against Mednet Healthcare Technologies, Inc. and its subsidiaries, Heart-Care Corporation of America, Universal Medical Inc., and Universal Medical Laboratory, Inc. ("Mednet"), as well as other named defendants. Mednet entered into a consent judgment, declaring that the Mednet entities infringed on five patents owned by BioTelemetry and its subsidiary, Braemar Manufacturing, and that all five patents are valid.
BioTelemetry is a remote medical technology company focused on delivery of health information. Co. provides remote cardiac monitoring, centralized core laboratory services, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. Co.'s segments are: Healthcare, which is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices; and Research, which is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, consulting and data management services for drug and medical device trials.
BEAT SEC Filing Email Alerts Service
Open the BEAT Page at The Online Investor »
Buy (3.00 out of 4)
(ranked lower than approx. 60% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite